iCare USA to Commercialize Oculo Software Solution Platform that Connects Doctors with Each Other and Their Patients

iCare USA’s parent company, Revenio, has announced its acquisition of Oculo, an Australian company dedicated to telehealth, remote patient monitoring, and clinical communications.

Terms of the deal were not disclosed. 

Oculo's software platform allows doctors to communicate and exchange clinical correspondence—such as patient referrals—securely and instantly, enabling faster, more efficient patient care. The software can also transfer clinical data and images in a secure and HIPAA-compliant way replacing FAX communications. iCare USA has the pleasure of introducing Oculo to the U.S. just as the Australian clinical communications company has fully integrated its newest feature—telemedicine—into its platform. iCare Oculo's telemedicine feature enables clinicians to arrange high-quality, completely secure video consultations from wherever there is internet.

With this acquisition, iCare is taking a major step forward in the rapidly growing areas of eye related telehealth and technology-enhanced eye care. iCare eye diagnostic solutions include intraocular pressure measuring devices, fundus imaging devices, and perimeters for diagnosing and monitoring glaucoma and retinal disease pathology.

"We are excited about this acquisition and the opportunity to improve eye care around the world together," Dr. Kate Taylor, Co-founder and former CEO of Oculo, now Director, Eyecare Solutions, said in a company news release. "By facilitating seamless communication among doctors and providing a virtual platform for interaction between eye care providers and their patients, we can help deliver better outcomes to patients."

The iCare Oculo platform bridges data silos in healthcare by allowing doctors to share valuable patient information such as imaging, test results, and referrals instantly and securely, regardless of location or EMR. "The Oculo platform provides an excellent solution for sharing data between referring doctors," said Michael V. Boland, MD, PhD, Associate Professor, Harvard Medical School and Medical Director of Practice Innovation, Department of Ophthalmology, Massachusetts Eye and Ear. "The ability to share high quality or original versions of tests and patient data is an appealing advance that has long been needed," he added.

iCare Oculo's user-friendly and reliable telemedicine platform has been a benefit to eye care providers who've had access to it during these unprecedented times when quarantine and social distancing mandates often made appointment scheduling challenging. 

"When COVID-19-quarantine rules went into effect, we needed a way to connect with patients that wasn't face to face, we looked into multiple telehealth solutions and Oculo stood out above the others," said Tyson Allard, OD, who is in private practice with True Vision Optometric Group, Oklahoma. "Many of our patients are ranchers who live in rural areas – many are not tech savvy and inadequate cell phone service is common in these areas. We wanted something straightforward and easy to use. With Oculo, I can connect with patients who are hours away. We have found that the program is easy to integrate into practice and simple for our patients to use."

To learn more about iCare Oculo, visit https://us.icare-world.com